You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 11, October 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  Drug Therapy
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Evaluation of Piperacillin Therapy for Infection

Steven Pancoast, MD; Alice S. Prince, MD; Elliot L. Francke, MD; Harold C. Neu, MD

Arch Intern Med. 1981;141(11):1447-1450.


Abstract

Piperacillin sodium, a semisynthetic penicillin that inhibits many Klebsiella and Pseudomonas aeruginosa organisms resistant to carbenicillin, was used to treat 41 episodes of infection in 35 patients. Infectious sites included lungs, urinary tract, and tissue, including peritonitis. Seven patients had bacteremia. Clinical and bacteriological cures were achieved in 85% of infections. Cure was achieved with piperacillin in patients infected with carbenicillin-resistant P aeruginosa and Klebsiella organisms. Adverse effects were minor and included rash in two patients. Serum levels were easily maintained above the inhibitory levels for susceptible organisms. Piperacillin was a safe, well-tolerated, and effective antimicrobial agent.

(Arch Intern Med 1981;141:1447-1450)



Author Affiliations

From the Division of Infectious Diseases, Departments of Medicine (Dr Pancoast, Francke, and Neu) and Pediatrics (Dr Prince), Columbia University College of Physicians and Surgeons, New York. Dr Pancoast is now at the Mercy and Moses-Taylor Hospital, Scranton, Pa. Dr Francke is now at Abbott-Northwestern Hospital, Minneapolis.


Footnotes

Accepted for publication Dec 22, 1980.

Reprint requests to 630 W 168th St, New York, NY 10032 (Dr Neu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Efficacy of Ceftazidime: Treatment of Serious Infection due to Multiresistant Pseudomonas and Other Gram-negative Bacteria
Scully and Neu
Arch Intern Med 1984;144:57-62.
ABSTRACT  

Azlocillin, Mezlocillin, and Piperacillin: New Broad-Spectrum Penicillins
ELIOPOULOS and MOELLERING
ANN INTERN MED 1982;97:755-760.
ABSTRACT  

Piperacillin Plus Amikacin Therapy v Carbenicillin Plus Amikacin Therapy in Febrile, Granulocytopenic Patients
Winston et al.
Arch Intern Med 1982;142:1663-1667.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.